Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA
Mandate

VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA

September 19, 2014

Vinge assists a group of Swedish investors through AdvInvest AB in connection with its acquisition financing and acquisition through AdvInvest of a majority stake in Advania. Advania is a Nordic IT company with approx. 1,100 employees in 17 offices in Iceland, Sweden and Norway. Beringer Finance assisted AdvInvest as corporate finance advisor.

Vinge’s team consisted of among others responsible partner Henrik Wenckert (M&A) and project manager Peter Sundgren (M&A) as well as associates Louise Brorsson Salomon (Banking & Finance), Oscar Rydén (Banking & Finance), Albert Wållgren (Banking & Finance), Filip Brosset (M&A), Johan Wahlbom (EU & Competition), Evelina Tejle (Employment & Benefits), Nicklas Thorgerzon (Technology & Outsourcing), Rebecka Weitzberg (Intellectual Property) and Daniel Unger (Real Estate).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025